A minority of cases of breast cancerscoring HER-2 (+3) by IHC using Herceptin test maynot be associated with findings obtained from CISH,which confirms that the CISH technique has a higheraccuracy and sensitivity (36). This evidence concerns the gene ERBB2 and neoplasm.